Senior insider sale
EVP, GMDA at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$8.78M
19.47K shares
BOZIC CARMEN plans to sell 19.47K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $8.78M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 1.02K | — |
| Total | 1.02K | ||
Completed
Units to sell
4.06K
Market value
$1.83M
Units to sell
1.75K
Market value
$785.3K
Units to sell
1.97K
Market value
$888.3K
Units to sell
1.35K
Market value
$614.0K
Units to sell
6.99K
Market value
$3.14M
Units to sell
2.33K
Market value
$1.05M
Planned — Approximate Date
Units to sell
1.02K
Market value
$471.4K
Units
19.47K
Value
$8.78M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/15/2026 | 4.06K | $1.83M | — | Completed |
6/5/2026 | 1.75K | $785.3K | — | Completed |
5/29/2026 | 1.97K | $888.3K | — | Completed |
5/15/2026 | 1.35K | $614.0K | — | Completed |
5/12/2026 | 6.99K | $3.14M | — | Completed |
3/27/2026 | 2.33K | $1.05M | — | Completed |
| Planned — Approximate Date | ||||
6/18/2026 | 1.02K | $471.4K | NASDAQ | Planned |
| Total | 19.47K | $8.78M | ||